The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation

ASAIO Journal

Volumn 45, Issue 4, 1999, Pages 250-263

  Peek, Giles J ^a   Firmin, Richard K ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; DRUG INFUSION; DRUG INTERACTIONS; HEMODYNAMICS; NONINVASIVE MEDICAL PROCEDURES;

COAGULATIVE RESPONSE; EXTRACORPOREAL MEMBRANE OXYGENATION; INFLAMMATORY RESPONSE;

MICROCIRCULATION;

APROTININ; BLOOD CLOTTING FACTOR; COMPLEMENT; CYTOKINE; FREE RADICAL; GAMMA INTERFERON; HEPARIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; PROTAMINE; SUPEROXIDE DISMUTASE; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTICOAGULATION; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; EXTRACORPOREAL OXYGENATION; HEMODIALYSIS; HEMODILUTION; HUMAN; HYPOTHERMIA; IMMUNE RESPONSE; ISCHEMIA; LEUKOCYTE ACTIVATION; MULTIPLE ORGAN FAILURE; REPERFUSION INJURY; RESPIRATORY DISTRESS SYNDROME; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE ACTIVATION;

EID: 0033492795     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199907000-00003     Document Type: Review

References (11)

1. Gulliver G: Works of William Hewson. London, Sydenham Society, 1846.
2. McLean J: The discovery of heparin. Circulation 19: 75, 1959.
3. Gibbon JH: Artificial maintenance of the circulation during experimental occlusion of the pulmonary artery. Arch Surg 34: 1105-1131, 1937.
4. Kirklin JW, Donald DE, Harshbarger HG, et al: Studies in extracorporeal circulation: I. Applicability of Gibbon-type pumpoxygenator to human intracardiac surgery: 40 cases. Ann Surg 144: 2-8, 1956.
5. Soils RT, Kennedy PS, Beall Jr. AC, Noon GP, DeBakey ME: Cardiopulmonary bypass: microembolization and platelet aggregation. Circulation 52: 103-108, 1975.
6. Reed CC, Romagnoli A, Taylor DE, Clark DK: Particulate matter in bubble oxygenators. J Thorac Cardiovasc Surg 68: 971-974, 1974.
7. Connell RS, Page US, Bartley TD, Bigelow JC, Webb MC: The effect on pulmonary ultrastructure of dacron-wool filtration during cardiopulmonary bypass. Ann Thorac Surg 15: 217-229, 1973.
8. Page US, Bigelow JC, Carter CR, Swank RL: Emboli (debris) produced by bubble oxygenators: removal by filtration. Ann Thorac Surg 18: 164-171, 1974.
9. Lee WH, Krumhaar D, Fonkalsrud EW, Schjeide OA, Maloney JV: Denaturation of plasma proteins as a cause of morbidity and death after cardiac operations. Surgery 50: 29-39, 1961.
10. Moat NE, Shore DF, Evans TW: Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins (Editorial). Eur J Cardiothorac Surg 7: 563-573, 1993.
11. Loop FD, Szabo J, Rowlinson RD, Urbanek K: Events related to microembolism during extracorporeal perfusion in man: effectiveness of in-line filtration recorded by ultrasound. Ann Thorac Surg 21: 412-420, 1976.